Dr. Debu Tripathy on Ribociclib Plus Hormone Therapy for Breast Cancer Patients

Cancer Network spoke with Debu Tripathy, MD, Chair of Breast Medical Oncology at MD Anderson Cancer Center, on how ribociclib plus hormone therapy extends survival for patients with premenopausal advanced HR-positive breast cancer.

Related Content:

ASCOBreast Cancer

Significant Interfacility Variation Found in Implementation of Low-Value Breast Cancer Procedures

Black Women With Node-Negative Breast Cancer More Likely to Have High-Risk Recurrence Scores Than Non-Hispanic White Women

Phase 3 OlympiA Trial for HER2-Negative Breast Cancer Moves to Early Primary Analysis Per IDMC Recommendation